These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36811444)

  • 1. Diabetic ketoacidosis with SGLT2 inhibitor use - a patient series.
    Lejlic S; Holmaas G; Løvås K; Ueland GÅ
    Tidsskr Nor Laegeforen; 2023 Feb; 143(3):. PubMed ID: 36811444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.
    Liu H; Sridhar VS; Perkins BA; Rosenstock J; Cherney DZI
    Curr Diab Rep; 2022 Jul; 22(7):317-332. PubMed ID: 35633439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normoglycaemic ketoacidosis induced by the use of sglt2 inhibitors : impact of intense physiological stress and fasting].
    Bayoudh S; Douws T; Canivet JL
    Rev Med Liege; 2024 Jan; 79(1):11-16. PubMed ID: 38223964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].
    Menghoum N; Oriot P; Hermans MP; Mariage JL
    Rev Med Interne; 2020 Apr; 41(4):226-231. PubMed ID: 31866073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
    Seger CD; Xing H; Wang L; Shin JS
    A A Pract; 2021 Jan; 15(1):e01380. PubMed ID: 33512907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives.
    Qiu H; Novikov A; Vallon V
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28099783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre prospective observational study of sodium-glucose cotransporter-2 inhibitor-associated postoperative ketoacidosis: the SAPKA study protocol.
    Seki H; Kuratani N; Shiga T; Iwasaki Y; Karita K; Yasuda K; Yorozu T
    BMJ Open; 2021 Nov; 11(11):e049592. PubMed ID: 34815277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis.
    Umapathysivam MM; Morgan B; Inglis JM; Meyer E; Liew D; Thiruvenkatarajan V; Jesudason D
    JAMA Netw Open; 2024 Mar; 7(3):e242744. PubMed ID: 38497966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
    Burke KR; Schumacher CA; Harpe SE
    Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
    Jeon JY; Kim SK; Kim KS; Song SO; Yun JS; Kim BY; Kim CH; Park SO; Hong S; Seo DH; Seo JA; Noh JH; Kim DJ;
    Diabetes Metab; 2019 Oct; 45(5):453-457. PubMed ID: 30639566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors After Cardiac Surgery: A Review of Current Literature.
    Branco A; Fatima R; Liblik K; Jackson R; Payne D; El-Diasty M
    J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3877-3886. PubMed ID: 35863986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
    Stougaard EB; Kristensen PL; Kielgast U; Andersen HU; Hamid Y; Gæde PH; Søndergaard E; Dørflinger GH; Fjeldborg KK; Hansen KW; Thomsen HH; Al-Imar TMJ; Røder M; Sridhar VS; Cherney D; Rossing P; Persson F
    Diab Vasc Dis Res; 2022; 19(5):14791641221130043. PubMed ID: 36262089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of a Severe Form of Euglycemic Ketoacidosis in a Patient Treated with SGLT-2 Inhibitors with the Aid of Somatostatin.
    Torre A; Bisogno N; Botta C; Caiazza A; D'Angelo F; Del Giudice L; Fiorentini P; Marzano L; Nigro R; Sassone D; Torre P; Vicedomini D
    G Ital Nefrol; 2023 Aug; 40(4):. PubMed ID: 37910214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin.
    Bardhi O; Bloom MD; Sattari M
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.
    Pfützner A; Klonoff D; Heinemann L; Ejskjaer N; Pickup J
    Endocrine; 2017 Apr; 56(1):212-216. PubMed ID: 28303514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter 2 inhibitor-induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction.
    Cavka L; Bencak Ferko U; Pitz N; Trpkovski Z; Lainscak M
    ESC Heart Fail; 2021 Aug; 8(4):2631-2636. PubMed ID: 34102028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
    Klinkner G; Steingraber-Pharr M
    AACN Adv Crit Care; 2023 Mar; 34(1):27-32. PubMed ID: 36877649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Allison R; Goldstein D; Musso MW
    J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.